AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wiederhold, N. P.
Right arrow Articles by Lewis, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiederhold, N. P.
Right arrow Articles by Lewis, R. E.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2005, p. 5146-5148, Vol. 49, No. 12
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.12.5146-5148.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Attenuation of the Activity of Caspofungin at High Concentrations against Candida albicans: Possible Role of Cell Wall Integrity and Calcineurin Pathways

Nathan P. Wiederhold,3,4* Dimitrios P. Kontoyiannis,1,2 Randall A. Prince,1,2 and Russell E. Lewis1

The University of Houston College of Pharmacy,1 The University of Texas M. D. Anderson Cancer Center, Houston, Texas,2 The University of Texas at Austin College of Pharmacy, Austin, Texas,3 The University of Texas Health Science Center at San Antonio, San Antonio, Texas4

Received 25 July 2005/ Returned for modification 6 September 2005/ Accepted 10 September 2005


   ABSTRACT
Top
 Abstract
Text
 References
 
Caspofungin had diminished activity in vitro against Candida albicans at concentrations of 8 to 32 µg/ml. This phenomenon was markedly attenuated in a {Delta}mkc1/{Delta}mkc1 deletion mutant and by the addition of cyclosporine to the wild type. Short exposure to these caspofungin concentrations resulted in MKC1 up-regulation, suggesting roles of cell wall integrity and calcineurin pathways.


   TEXT
Top
 Abstract
 Text
References
 
The safety profile and clinical efficacy of caspofungin (CAS) has raised questions as to whether its effectiveness could be further improved by administering higher dosages. However, in vitro studies as well as some dosage escalation studies in animals have reported a paradoxical attenuation of CAS activity at higher drug concentrations (5, 17, 21, 23). These concentrations are comparable to plasma CAS levels achieved in humans at recommended doses (22). The mechanism of the attenuated CAS activity at higher concentrations and its clinical relevance are unknown. Studies of the genetically amenable yeast Saccharomyces cerevisiae have suggested links with both the intracellular protein kinase C (PKC) cell wall integrity and calcineurin pathways (1, 4, 7, 13, 18, 20). In view of the evolutionary conservation of several key cellular processes, including homeostatic responses toward drug-induced damage of the fungal cell wall (2, 19), we hypothesized that the cell wall integrity and calcineurin pathways may play an important role in the paradoxical attenuation of CAS activity at supra-MIC exposures. To this end, we examined expression levels of MKC1, a central kinase of the PKC pathway in Candida albicans, and the effects of MKC1 gene deletion on the paradoxical activity observed with CAS. We also explored the importance of the calcineurin pathway in the attenuation of CAS activity at high doses by testing isolates in the presence of the calcineurin inhibitor cyclosporine.

(This research was presented in part at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, D.C., 30 October to 2 November 2004 [abstract M-1682].)

We tested Candida albicans strain ATCC 90028, a C. albicans {Delta}mkc1/{Delta}mkc1 homozygous mutant ({Delta}mkc1::hisG-URA3-hisG/{Delta}mkc1::hisG-{Delta}ura3::imm434/{Delta}ura3::imm434) (15), and the corresponding isogenic wild-type strain CAI4 ({Delta}ura3::imm434/{Delta}ura3::imm434) (3). Fresh stock solutions were prepared by dissolving caspofungin acetate powder (Merck & Co., Inc., Whitehouse Station, NJ) in 0.85% saline. Fresh stocks of cyclosporine (Sigma, St. Louis, MO) were prepared in 100% ethanol and further diluted in RPMI 1640 buffered with 0.165 M morpholinepropanesulfonic acid (MOPS; pH 7.0). 2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT)-based in vitro viability studies were conducted at CAS concentrations from 0 to 1,024 µg/ml using a modification of the method reported by Meletiadis et al. (12). All isolates were also tested in the presence of CAS plus cyclosporine (0.625 µg/ml). Absorbance was read at 492 nm, and readings were converted to percent absorbance, with the growth control set at 100% and the medium control at 0%.

For gene expression analysis, C. albicans strain ATCC 90028 was adjusted to an inoculum of ~5 x 105 CFU/ml and incubated at 37°C with shaking to the midlogarithmic growth phase. Yeast cells were then exposed to CAS (0, 0.03, 1.0, 16.0, and 64.0 µg/ml) for 10 min. This brief exposure time was chosen in view of the fact that the transcription of SLT2 mRNA in S. cerevisiae (the homologue of MKC1 in C. albicans) in response to CAS is rapid and transient (18). Cells were harvested, and total RNA was extracted using QIAGEN RNeasy Protect mini kits (QIAGEN, Valencia, CA). Reverse transcription was performed (GeneAmp RNA PCR kit; Applied Biosystems, Inc., Foster City, CA), and relative gene expression was determined using real-time PCR (ABI PRISM 7000 sequence detection system) with primers and probes specific for DNA encoding MKC1 (GenBank accession no. X76708) (14). Relative gene expression levels were calculated by the 2–{Delta}{Delta}CT method using 18S rRNA as the housekeeping gene (9). One-way analysis of variance with Bonferroni's correction for multiple comparisons was used to assess differences in CAS activity. Changes in gene expression were compared by analysis of variance with Tukey's posttest. All experiments were performed in at least triplicate on separate days.

CAS demonstrated marked concentration-dependent activity against both wild-type C. albicans strains (ATCC 90028 and CAI4), with a 95 to 100% reduction in absorbance at 1 to 2 µg/ml and a significant paradoxical increase in viability at CAS concentrations ranging from 8 to 32 µg/ml (16 to 64x MIC) (Fig. 1A). In contrast, the paradoxical effect of CAS against the {Delta}mkc1/{Delta}mkc1 isolate was significantly decreased. In addition, short exposure (10 min) of the C. albicans ATCC 90028 strain to higher CAS concentrations (16 and 64 µg/ml) increased MKC1 transcription compared to what occurred with lower concentrations (Fig. 1B). Our data and those of others (1, 18) show that a rapid and transient induction of genes encoding components of the cell wall integrity pathway occurs in response to CAS. Furthermore, in a large-scale genome-wide screen of S. cerevisiae deletion mutants, four genes of the PKC cell wall integrity pathway (SLG1, BCK1, FKS1, and SMI1/KNR4) were identified as affecting the sensitivity of S. cerevisiae specifically to CAS (10). In contrast, Liu et al., in a recent genome-wide expression profiling study of C. albicans including subinhibitory concentrations of CAS for 180 min found that the induction of PKC genes was not prominent (8). Future genome-wide approaches that compare exposures of C. albicans at different time intervals to either subinhibitory or inhibitory concentrations of CAS associated with the paradoxical effect and the use of other antifungal agents as controls (e.g., azoles, amphotericin B) would be informative to further address the specificity of up-regulation of PKC-encoding genes in the attenuation of cidality following exposure to high concentrations of cell wall-active agents. Assessment of the active phosphorylated Mkc1p protein on the downstream targets of the cell wall integrity pathway upon exposure to CAS may be further informative.



View larger version (16K):
[in this window]
[in a new window]
  		FIG. 1. (A) In vitro viability assay for XTT. Percentages of viability (means ± standard errors of the means [SEM] as measured at 492 nm) relative to the viability of the control are plotted on the y axis, and increasing concentrations of caspofungin (0 to 1,024 µg/ml) are plotted on the x axis. A decrease in the paradoxical attenuation of caspofungin activity was observed in the {Delta}mkc1/{Delta}mkc1 homozygous-knockout mutant compared to that of C. albicans strain ATCC 90028 and the parent strain CAI4 (*, P < 0.001 for {Delta}mkc1/{Delta}mkc1 at concentrations of 8 to 32 µg/ml). {blacksquare}, C. albicans strain ATCC 90028; •, CAI4; {circ}, {Delta}mkc1/{Delta}mkc1 strain. (B) Relative MKC1 gene expression in Candida albicans strain ATCC 90028 (mean + SEM). Changes in gene expression compared to that of cells not exposed to caspofungin are plotted on the y axis and capsofungin concentrations on the x axis. Expression levels were normalized to 18S rRNA.

 
In view of the fact that a functional link might exist between the calcineurin pathway of fungi and the tolerance to antifungal agents (2, 6), we examined whether the addition of cyclosporine, a known inhibitor of the calcineurin pathway, modulates the paradoxical CAS effect. Indeed, the paradoxical effect was completely absent in both wild-type strains at a cyclosporine concentration of 0.625 µg/ml (Fig. 2), while the other portions of the CAS dose-response curve remained unchanged. Future studies examining the use of other calcineurin inhibitors and utilizing genome-wide expression profiling will be of interest.



View larger version (22K):
[in this window]
[in a new window]
  		FIG. 2. In vitro viability assay for XTT. Percentages of viability (means ± standard errors of the means as measured at 492 nm) relative to the viability of the control are plotted on the y axis, and increasing concentrations of caspofungin (0 to 1,024 µg/ml) in the presence of cyclosporine (0.625 µg/ml) are plotted on the x axis. {blacksquare}, C. albicans strain ATCC 90028; •, CAI4; {circ}, {Delta}mkc1/{Delta}mkc1 strain.

 
Our data indicate that, following exposure of C. albicans to high CAS concentrations, calcineurin-mediated and PKC-mediated signaling pathways act to regulate the functionally redundant cellular events important in resisting the toxic effects of CAS. In fact, cell wall integrity and calcineurin pathways have been shown to perform independent but related functions in S. cerevisiae (13). Alternatively, other indirect mechanisms might be operative in the phenomenon of the attenuated cidality of high concentrations of CAS. Up-regulation of 1,3-ß-glucan synthesis, increases in the chitin content of the cell wall, and increased export of cell wall components for cell wall repair (10, 11, 16, 20, 24) need further investigation.

These preliminary data should invite further studies of the role of the PKC and calcineurin pathways in the orchestrated regulation of cell wall-sensing pathways, the stress response, and the activities of the echinocandins.


   ACKNOWLEDGMENTS
 
A University of Texas M. D. Anderson faculty E. N. Cobb Scholar Award Research Endowment was given to D.P.K. R.E.L. received research support from and served as a consultant to Merck & Co., Pfizer, Astellas, Enzon, and Schering-Plough; D.P.K. received research support from and served as a consultant to Merck & Co., Pfizer, Astellas, Enzon, and Schering-Plough; and R.A.P. received research support from Merck & Co., Bristol Myers Squibb, Pfizer, Ortho McNeil, and Enzon.

Isolates (CAI4 and the {Delta}mkc1/{Delta}mkc1 isolate) were kindly provided by Jesús Pla, Universidad Complutense de Madrid, Madrid, Spain, and P. David Rogers, University of Tennessee Health Science Center.


   FOOTNOTES
 
* Corresponding author. Mailing address for Nathan P. Wiederhold: University of Texas at Austin College of Pharmacy, 7703 Floyd Curl Dr., MSC 6220, San Antonio, TX 78229. Phone: (210) 567-8340. Fax: (210) 567-8328. E-mail: wiederholdn{at}uthscsa.edu. Mailing address for Russell E. Lewis: University of Houston College of Pharmacy, 1441 Moursund Street, no. 423, Houston, TX 77030. Phone: (713) 795-8326. Fax: (713) 795-8383. E-mail: rlewis{at}uh.edu. Back


   REFERENCES
Top
 Abstract
 Text
 References
 

  1. Agarwal, A. K., P. D. Rogers, S. R. Baerson, M. R. Jacob, K. S. Barker, J. D. Cleary, L. A. Walker, D. G. Nagle, and A. M. Clark. 2003. Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae. J. Biol. Chem. 278:34998-35015.[Abstract/Free Full Text]
  2. Cruz, M. C., A. L. Goldstein, J. R. Blankenship, M. Del Poeta, D. Davis, M. E. Cardenas, J. R. Perfect, J. H. McCusker, and J. Heitman. 2002. Calcineurin is essential for survival during membrane stress in Candida albicans. EMBO J. 21:546-559.[CrossRef][Medline]
  3. Fonzi, W. A., and M. Y. Irwin. 1993. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134:717-728.[Abstract]
  4. Hemenway, C. S., and J. Heitman. 1999. Calcineurin. Structure, function, and inhibition. Cell Biochem. Biophys. 30:115-151.[Medline]
  5. Ibrahim, A. S., J. C. Bowman, V. Avanessian, K. Brown, B. Spellberg, J. E. Edwards, Jr., and C. M. Douglas. 2005. Caspofungin inhibits Rhizopus oryzae 1,3-ß-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis. Antimicrob. Agents Chemother. 49:721-727.[Abstract/Free Full Text]
  6. Kontoyiannis, D. P., R. E. Lewis, N. Osherov, N. D. Albert, and G. S. May. 2003. Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species. J. Antimicrob. Chemother. 51:313-316.[Abstract/Free Full Text]
  7. Kurtz, M. B., and C. M. Douglas. 1997. Lipopeptide inhibitors of fungal glucan synthase. J. Med. Vet. Mycol. 35:79-86.[Medline]
  8. Liu, T. T., R. E. Lee, K. S. Barker, L. Wei, R. Homayouni, and P. D. Rogers. 2005. Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob. Agents Chemother. 49:2226-2236.[Abstract/Free Full Text]
  9. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the method. Methods 25:402-408.[CrossRef][Medline]
  10. Markovich, S., A. Yekutiel, I. Shalit, Y. Shadkchan, and N. Osherov. 2004. Genomic approach to identification of mutations affecting caspofungin susceptibility in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 48:3871-3876.[Abstract/Free Full Text]
  11. Mazur, P., N. Morin, W. Baginsky, M. el-Sherbeini, J. A. Clemas, J. B. Nielsen, and F. Foor. 1995. Differential expression and function of two homologous subunits of yeast 1,3-ß-D-glucan synthase. Mol. Cell. Biol. 15:5671-5681.[Abstract]
  12. Meletiadis, J., J. W. Mouton, J. F. Meis, B. A. Bouman, J. P. Donnelly, and P. E. Verweij. 2001. Colorimetric assay for antifungal susceptibility testing of Aspergillus species. J. Clin. Microbiol. 39:3402-3408.[Abstract/Free Full Text]
  13. Nakamura, T., T. Ohmoto, D. Hirata, E. Tsuchiya, and T. Miyakawa. 1996. Genetic evidence for the functional redundancy of the calcineurin- and Mpk1-mediated pathways in the regulation of cellular events important for growth in Saccharomyces cerevisiae. Mol. Gen. Genet. 251:211-219.[Medline]
  14. Navarro-Garcia, F., R. Alonso-Monge, H. Rico, J. Pla, R. Sentandreu, and C. Nombela. 1998. A role for the MAP kinase gene MKC1 in cell wall construction and morphological transitions in Candida albicans. Microbiology 144:411-424.[Abstract]
  15. Navarro-García, F., M. Sánchez, J. Pla, and C. Nombela. 1995. Functional characterization of the MKC1 gene of Candida albicans, which encodes a mitogen-activated protein kinase homolog related to cell integrity. Mol. Cell. Biol. 15:2197-2206.[Abstract]
  16. Osherov, N., G. S. May, N. D. Albert, and D. P. Kontoyiannis. 2002. Overexpression of Sbe2p, a Golgi protein, results in resistance to caspofungin in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 46:2462-2469.[Abstract/Free Full Text]
  17. Ramage, G., K. VandeWalle, S. P. Bachmann, B. L. Wickes, and J. L. Lopez-Ribot. 2002. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob. Agents Chemother. 46:3634-3636.[Abstract/Free Full Text]
  18. Reinoso-Martin, C., C. Schuller, M. Schuetzer-Muehlbauer, and K. Kuchler. 2003. The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling. Eukaryot. Cell 2:1200-1210.[Abstract/Free Full Text]
  19. Sanglard, D., F. Ischer, O. Marchetti, J. Entenza, and J. Bille. 2003. Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence. Mol. Microbiol. 48:959-976.[CrossRef][Medline]
  20. Smits, G. J., H. van den Ende, and F. M. Klis. 2001. Differential regulation of cell wall biogenesis during growth and development in yeast. Microbiology 147:781-794.[Free Full Text]
  21. Stevens, D. A., M. Espiritu, and R. Parmar. 2004. Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrob. Agents Chemother. 48:3407-3411.[Abstract/Free Full Text]
  22. Stone, J. A., S. D. Holland, P. J. Wickersham, A. Sterrett, M. Schwartz, C. Bonfiglio, M. Hesney, G. A. Winchell, P. J. Deutsch, H. Greenberg, T. L. Hunt, and S. A. Waldman. 2002. Single- and multiple-dose pharmacokinetics of caspofungin in healthy men. Antimicrob. Agents Chemother. 46:739-745.[Abstract/Free Full Text]
  23. Wiederhold, N. P., D. P. Kontoyiannis, J. Chi, R. A. Prince, V. H. Tam, and R. E. Lewis. 2004. Pharmacodynamics of caspofungin in a murine model of invasive pulmonary aspergillosis: evidence of concentration-dependent activity. J. Infect. Dis. 190:1464-1471.[CrossRef][Medline]
  24. Zhao, C., U. S. Jung, P. Garrett-Engele, T. Roe, M. S. Cyert, and D. E. Levin. 1998. Temperature-induced expression of yeast FKS2 is under the dual control of protein kinase C and calcineurin. Mol. Cell. Biol. 18:1013-1022.[Abstract/Free Full Text]

Antimicrobial Agents and Chemotherapy, December 2005, p. 5146-5148, Vol. 49, No. 12
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.12.5146-5148.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wiederhold, N. P.
Right arrow Articles by Lewis, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiederhold, N. P.
Right arrow Articles by Lewis, R. E.

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS